{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:16:06Z","timestamp":1776741366814,"version":"3.51.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma (MPM) is highly abandoned due to high morbidity and mortality rates and impaired quality of life (QoL). However, there are still rare indications for this intervention. The aim of this longitudinal prospective study was to monitor QoL and lung function in patients undergoing EPP and compare the outcomes with extended pleurectomy\/decortication [(E)PD].<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Between June 2013 and June 2017, 42 patients underwent induction chemotherapy followed by either EPP (<jats:italic>n<\/jats:italic> = 7) or (E)PD (<jats:italic>n<\/jats:italic> = 35). All patients filled out the EORTC QLC-C15-PAL, \u2013LC13, and SF-36 self-rating questionnaires pre-operatively, 6 weeks and 4 months after the operation. Additionally, lung function was measured pre-operatively and 4 months post-operatively.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We observed no significant differences in all QoL categories (general global health, pain, and dyspnea) between both surgical procedures, over the whole observation period. Moreover, a general tendency toward restoration of the pre-operative QoL status was documented at 4 months after the both operations. Forced expiratory volume in 1 s (FEV1) showed a significant decrease after surgery in both the groups [EPP group <jats:italic>p<\/jats:italic> = 0.06 and (E)PD group <jats:italic>p<\/jats:italic> &amp;lt; 0.001]; also, the forced volume vital capacity (FVC) significantly decreased (EPP group <jats:italic>p<\/jats:italic> = 0.046 P\/D group &amp;lt;0.001). Diffusion capacity did not show significant changes.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> According to these results, QoL is no longer severely impaired after EPP compared with EPD, and therefore should not be used as an argument against EPP in principle. However, indication has to be carefully evaluated for each patient.<\/jats:p>","DOI":"10.3389\/fsurg.2021.766033","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T04:27:23Z","timestamp":1638937643000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Quality of Life Is Not Deteriorated After Extrapleural Pneumonectomy vs. (Extended) Pleurectomy\/Decortication in Patients With Malignant Pleural Mesothelioma"],"prefix":"10.3389","volume":"8","author":[{"given":"Olivia","family":"Lauk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Patella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Neuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhan","family":"Inci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ejcts\/ezaa158","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"58","author":"Opitz","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0140-6736(08)60703-5","article-title":"Chemotherapy for malignant pleural mesothelioma","volume":"371","author":"Vogelzang","year":"2008","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extrapleural pneumonectomy versus no extrapleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0218492312454017","article-title":"Changes in lung function after surgery for mesothelioma","volume":"21","author":"Ploenes","year":"2013","journal-title":"Asian Cardiovasc Thorac Ann."},{"key":"B5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.lungcan.2011.12.009","article-title":"Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure","volume":"77","author":"Rena","year":"2012","journal-title":"Lung Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.21037\/atm.2017.03.41","article-title":"The impact of surgical approach on quality of life for pleural malignant mesothelioma","volume":"5","author":"Schwartz","year":"2017","journal-title":"Ann Transl Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","article-title":"Overview of the SF-36 health survey and the international quality of Life Assessment (IQOLA) project","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejca.2005.06.022","article-title":"The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care","volume":"42","author":"Groenvold","year":"2006","journal-title":"Eur J Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s11136-007-9210-8","article-title":"Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting","volume":"16","author":"Nicklasson","year":"2007","journal-title":"Qual Life Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/ejcts\/ezv398","article-title":"Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma","volume":"49","author":"Kostron","year":"2016","journal-title":"Eur J Cardiothorac Surg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/icvts\/ivw422","article-title":"Propensity matched comparison of extrapleural pneumonectomy and pleurectomy\/decortication for mesothelioma patients","volume":"24","author":"Kostron","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"31613","DOI":"10.1016\/j.jtcvs.2019.07.073","article-title":"Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: a phase I trial","volume":"19","author":"Opitz","year":"2019","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","article-title":"A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma","volume":"83","author":"Cao","year":"2014","journal-title":"Lung Cancer."}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.766033\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T04:27:25Z","timestamp":1638937645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.766033\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":13,"alternative-id":["10.3389\/fsurg.2021.766033"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2021.766033","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"article-number":"766033"}}